ZNF845 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.792000E-01
Normal-vs-Stage2
2.287200E-01
Normal-vs-Stage3
1.166280E-02
Normal-vs-Stage4
3.522200E-01
Stage1-vs-Stage2
5.806000E-01
Stage1-vs-Stage3
3.919600E-02
Stage1-vs-Stage4
7.707700E-02
Stage2-vs-Stage3
1.359980E-01
Stage2-vs-Stage4
8.771600E-04
Stage3-vs-Stage4
5.851700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.353000E-01
Normal-vs-AfricanAmerican
4.219200E-01
Normal-vs-Asian
1.410180E-01
Caucasian-vs-AfricanAmerican
7.873800E-01
Caucasian-vs-Asian
4.995200E-01
AfricanAmerican-vs-Asian
5.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.219200E-01
Normal-vs-Female
2.741400E-01
Male-vs-Female
5.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.980210E-01
Normal-vs-Age(41-60Yrs)
3.802000E-01
Normal-vs-Age(61-80Yrs)
2.279200E-01
Normal-vs-Age(81-100Yrs)
3.484300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.514400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.951000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.568000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.357210E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.943900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.066000E-02
Normal-vs-Daily Drinker
1.406620E-01
Normal-vs-Weekly Drinker
2.093600E-01
Normal-vs-Occasional Drinker
6.015600E-01
Normal-vs-Social Drinker
1.966240E-01
Non Drinker-vs-Daily Drinker
4.654200E-01
Non Drinker-vs-Weekly Drinker
2.838200E-01
Non Drinker-vs-Occasional Drinker
2.621800E-02
Non Drinker-vs-Social Drinker
7.862300E-02
Daily Drinker-vs-Weekly Drinker
7.383600E-01
Daily Drinker-vs-Occasional Drinker
1.190960E-01
Daily Drinker-vs-Social Drinker
4.119000E-01
Weekly Drinker-vs-Occasional Drinker
2.788800E-01
Weekly Drinker-vs-Social Drinker
6.749000E-01
Occasional Drinker-vs-Social Drinker
4.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.763400E-01
Normal-vs-Grade 2
8.864200E-02
Normal-vs-Grade 3
6.534300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.692790E-01
Grade 1-vs-Grade 3
5.718000E-02
Grade 1-vs-Grade 4
2.763400E-01
Grade 2-vs-Grade 3
3.080400E-01
Grade 2-vs-Grade 4
8.864200E-02
Grade 3-vs-Grade 4
6.534300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.650840E-01
Normal-vs-NonDiabetic
1.721820E-01
Diabetic-vs-NonDiabetic
6.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.522300E-02
Normal-vs-NoPancreatitis
2.176000E-01
Pancreatitis-vs-NoPancreatitis
1.068820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.453980E-01
Normal-vs-N1
2.922200E-01
N0-vs-N1
3.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.038600E-01
Normal-vs-TP53-NonMutant
2.815600E-01
TP53-Mutant-vs-TP53-NonMutant
5.097900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
